KORU Medical Systems (KRMD) Cash & Equivalents (2010 - 2026)

KORU Medical Systems (KRMD) has 13 years of Cash & Equivalents data on file, last reported at $8.8 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 0.73% year-over-year to $8.8 million in Q1 2026; TTM through Mar 2026 was $8.8 million, a 0.73% increase from a year earlier, with the FY2025 full-year figure at $8.9 million, down 7.4% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $8.8 million, down from $8.9 million in the prior quarter.
• Over the last five years, Cash & Equivalents for KRMD reached as high as $22.6 million in Q1 2022 and fell as low as $8.1 million in Q2 2025.
• Historically, Cash & Equivalents has averaged $12.0 million across 5 years, with a median of $10.8 million in 2023.
• Across the five-year window, Cash & Equivalents plunged 45.85% in 2023 and climbed 0.73% in 2026, its largest moves.
• Year by year, Cash & Equivalents stood at $17.4 million in 2022, then sank by 34.04% to $11.5 million in 2023, then declined by 16.56% to $9.6 million in 2024, then decreased by 7.4% to $8.9 million in 2025, then declined by 0.81% to $8.8 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $8.8 million in Q1 2026, $8.9 million in Q4 2025, and $8.5 million in Q3 2025.